329 related articles for article (PubMed ID: 9121973)
1. Low energy transvenous cardioversion of short duration atrial tachyarrhythmias in humans using a single lead system.
Heisel A; Jung J; Fries R; Stopp M; Sen S; Schieffer H; Ozbek C
Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):65-71. PubMed ID: 9121973
[TBL] [Abstract][Full Text] [Related]
2. Arrhythmias in the intensive care patient.
Trappe HJ; Brandts B; Weismueller P
Curr Opin Crit Care; 2003 Oct; 9(5):345-55. PubMed ID: 14508146
[TBL] [Abstract][Full Text] [Related]
3. Low-energy transvenous cardioversion defibrillation of atrial tachyarrhythmias in the canine: an assessment of electrode configurations and monophasic pulse sequencing.
Benditt DG; Dunbar D; Fetter J; Sakaguchi S; Lurie KG; Adler SW
Am Heart J; 1994 Apr; 127(4 Pt 2):994-1003. PubMed ID: 8160604
[TBL] [Abstract][Full Text] [Related]
4. Low energy endocardial cardioversion of atrial arrhythmias in humans.
Kalman JM; Jones EF; Doolan L; Oliver LE; Power JM; Tonkin AM
Pacing Clin Electrophysiol; 1995 Oct; 18(10):1869-75. PubMed ID: 8539154
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias.
Gold MR; Sulke N; Schwartzman DS; Mehra R; Euler DE;
J Cardiovasc Electrophysiol; 2001 Nov; 12(11):1247-53. PubMed ID: 11761411
[TBL] [Abstract][Full Text] [Related]
6. Clinical transvenous cardioversion of recurrent life-threatening ventricular tachyarrhythmias: low energy synchronized cardioversion of ventricular tachycardia and termination of ventricular fibrillation in patients using a catheter electrode.
Zipes DP; Jackman WM; Heger JJ; Chilson DA; Browne KF; Naccarelli GV; Rahilly GT; Prystowsky EN
Am Heart J; 1982 May; 103(5):789-94. PubMed ID: 7072583
[TBL] [Abstract][Full Text] [Related]
7. Effect of coronary sinus electrode on the optimal atrial defibrillation pathway for an atrioventricular defibrillator.
Tse HF; Timmermans C; Rodriguez LM; Lau CP; Wellens HJ
J Cardiovasc Electrophysiol; 2003 Jan; 14(1):32-7. PubMed ID: 12625607
[TBL] [Abstract][Full Text] [Related]
8. Effect of parenteral d-sotalol on transvenous atrial defibrillation threshold in a canine model of atrial fibrillation.
Iskos D; Lurie KG; Adler SW; Shultz JJ; Coffeen PR; Mulligan KA; Benditt DG
Am Heart J; 1996 Jul; 132(1 Pt 1):116-9. PubMed ID: 8701851
[TBL] [Abstract][Full Text] [Related]
9. Importance of electrode design, lead configuration and impedance for successful low energy transcatheter atrial defibrillation in dogs.
Kalman JM; Power JM; Chen JM; Farish SJ; Tonkin AM
J Am Coll Cardiol; 1993 Oct; 22(4):1199-206. PubMed ID: 8409061
[TBL] [Abstract][Full Text] [Related]
10. Internal cardioversion of chronic atrial fibrillation in patients.
Neri R; Palermo P; Cesario AS; Baragli D; Amici E; Gambelli G
Pacing Clin Electrophysiol; 1997 Sep; 20(9 Pt 1):2237-42. PubMed ID: 9309749
[TBL] [Abstract][Full Text] [Related]
11. Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial.
Singh SN; Tang XC; Reda D; Singh BN
Heart Rhythm; 2009 Feb; 6(2):152-5. PubMed ID: 19187902
[TBL] [Abstract][Full Text] [Related]
12. Transvenous atrial cardioversion threshold in patients with implantable cardioverter defibrillator: influence of active pectoral can.
Heisel A; Jung J; Nikoloudakis N; Fries R; Schäfers HJ; Schieffer H
Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 2):253-7. PubMed ID: 9990641
[TBL] [Abstract][Full Text] [Related]
13. Initial clinical experience with an implantable human atrial defibrillator.
Lau CP; Tse HF; Lok NS; Lee KL; Ho DS; Sopher M; Murgatroyd F; Camm AJ
Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 2):220-5. PubMed ID: 9121994
[TBL] [Abstract][Full Text] [Related]
14. Improved clinical efficacy of external cardioversion by fluoroscopic electrode positioning and comparison to internal cardioversion in patients with atrial fibrillation.
Mehdirad AA; Clem KL; Love CJ; Nelson SD; Schaal SF
Pacing Clin Electrophysiol; 1999 Jan; 22(1 Pt 2):233-7. PubMed ID: 9990637
[TBL] [Abstract][Full Text] [Related]
15. Low-energy transvenous cardioversion of atrial fibrillation using a single atrial lead system.
Heisel A; Jung J; Neuzner J; Michel U; Pitschner H
J Cardiovasc Electrophysiol; 1997 Jun; 8(6):607-14. PubMed ID: 9209961
[TBL] [Abstract][Full Text] [Related]
16. Internal cardioversion of atrial fibrillation in sheep.
Cooper RA; Alferness CA; Smith WM; Ideker RE
Circulation; 1993 May; 87(5):1673-86. PubMed ID: 8491023
[TBL] [Abstract][Full Text] [Related]
17. Clinical shock tolerability and effect of different right atrial electrode locations on efficacy of low energy human transvenous atrial defibrillation using an implantable lead system.
Lok NS; Lau CP; Tse HF; Ayers GM
J Am Coll Cardiol; 1997 Nov; 30(5):1324-30. PubMed ID: 9350935
[TBL] [Abstract][Full Text] [Related]
18. Multistage electrotherapy delivered through chronically-implanted leads terminates atrial fibrillation with lower energy than a single biphasic shock.
Janardhan AH; Gutbrod SR; Li W; Lang D; Schuessler RB; Efimov IR
J Am Coll Cardiol; 2014 Jan 7-14; 63(1):40-8. PubMed ID: 24076284
[TBL] [Abstract][Full Text] [Related]
19. Transvenous internal cardioversion for atrial fibrillation: a randomized study on defibrillation threshold and tolerability of asymmetrical compared with symmetrical shocks.
Boriani G; Biffi M; Zannoli R; Branzi A; Magnani B
Int J Cardiol; 1999 Sep; 71(1):63-9. PubMed ID: 10522566
[TBL] [Abstract][Full Text] [Related]
20. Effect of electrode position on outcome of low-energy intracardiac cardioversion of atrial fibrillation.
Alt E; Schmitt C; Ammer R; Plewan A; Evans F; Pasquantonio J; Ideker T; Lehmann G; Pütter K; Schömig A
Am J Cardiol; 1997 Mar; 79(5):621-5. PubMed ID: 9068520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
